![A new clinical-genomic model to predict 10-year recurrence risk in primary operable breast cancer patients | Scientific Reports A new clinical-genomic model to predict 10-year recurrence risk in primary operable breast cancer patients | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-61535-9/MediaObjects/41598_2020_61535_Fig1_HTML.png)
A new clinical-genomic model to predict 10-year recurrence risk in primary operable breast cancer patients | Scientific Reports
![The prognostic and predictive potential of Ki-67 in triple-negative breast cancer | Scientific Reports The prognostic and predictive potential of Ki-67 in triple-negative breast cancer | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-019-57094-3/MediaObjects/41598_2019_57094_Fig1_HTML.png)
The prognostic and predictive potential of Ki-67 in triple-negative breast cancer | Scientific Reports
![Galen eCalcs - Calculator: Breast Cancer Risk - Galen Healthcare Solutions - Allscripts TouchWorks EHR Wiki Galen eCalcs - Calculator: Breast Cancer Risk - Galen Healthcare Solutions - Allscripts TouchWorks EHR Wiki](https://wiki.galenhealthcare.com/images/f/f0/CancerImage01.png)
Galen eCalcs - Calculator: Breast Cancer Risk - Galen Healthcare Solutions - Allscripts TouchWorks EHR Wiki
![Cancers | Free Full-Text | piNET–An Automated Proliferation Index Calculator Framework for Ki67 Breast Cancer Images Cancers | Free Full-Text | piNET–An Automated Proliferation Index Calculator Framework for Ki67 Breast Cancer Images](https://pub.mdpi-res.com/cancers/cancers-13-00011/article_deploy/html/images/cancers-13-00011-g001.png?1609221778)
Cancers | Free Full-Text | piNET–An Automated Proliferation Index Calculator Framework for Ki67 Breast Cancer Images
![A clinical calculator to predict disease outcomes in women with hormone receptor-positive advanced breast cancer treated with first-line endocrine therapy | Request PDF A clinical calculator to predict disease outcomes in women with hormone receptor-positive advanced breast cancer treated with first-line endocrine therapy | Request PDF](https://i1.rgstatic.net/publication/352975101_A_clinical_calculator_to_predict_disease_outcomes_in_women_with_hormone_receptor-positive_advanced_breast_cancer_treated_with_first-line_endocrine_therapy/links/60e1422e458515d6fbfa3eee/largepreview.png)
A clinical calculator to predict disease outcomes in women with hormone receptor-positive advanced breast cancer treated with first-line endocrine therapy | Request PDF
![Cancers | Free Full-Text | Definition of High-Risk Early Hormone-Positive HER2−Negative Breast Cancer: A Consensus Review Cancers | Free Full-Text | Definition of High-Risk Early Hormone-Positive HER2−Negative Breast Cancer: A Consensus Review](https://www.mdpi.com/cancers/cancers-14-01898/article_deploy/html/images/cancers-14-01898-g001.png)
Cancers | Free Full-Text | Definition of High-Risk Early Hormone-Positive HER2−Negative Breast Cancer: A Consensus Review
![Validation of the CancerMath prognostic tool for breast cancer in Southeast Asia | BMC Cancer | Full Text Validation of the CancerMath prognostic tool for breast cancer in Southeast Asia | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-016-2841-9/MediaObjects/12885_2016_2841_Fig3_HTML.gif)